Ivette Ramirez Email & Phone Number

New York, Ny, Us

New York, Ny

• Design, develop and deploy innovative launch strategies aligned with business impact, patient access, market potential and competitive advantage. • Partner with Country and Commercial Teams to launch assets. Launched Zavicefta, Zinforo, Cresemba, Paxlovid, Oxbryta, Ngenla, and Vyndamax in 35 Emerging Markets (EM). • Accelerate pricing negotiations, reimbursement approvals and formulary inclusions by implementing market access strategies. Negotiated Paxlovid prices with government agencies during Covid Pandemic and signed 15 APAs (Advance Purchase Agreement). • Guide local teams to expedite the establishment of market access plans, affordability solutions and customization of global resources. Coached local teams in the commercialization of Paxlovid and transformation of payer relationships from bilateral agreements to full commercialization. • Foster global alignment and process optimization by sharing best practices. Led the implementation of national reimbursement programs for Zavicefta and Vyndamax in 9 EMs.

New York, Ny

• Created and executed dynamic global access strategies for public and private sectors, including sterile injectables, anti-infectives (AI) and biosimilars focused on healthcare systems’ intricacies.• Implemented the first Innovative Agreement (Capitation Price per Patient) for the AI Portfolio. • Issued tailored proposals for payer strategies, pricing and reimbursement, evidence generation, data collection, and value proposition to maximize patient access and value for Pfizer. • Partnered with Corporate Affairs, International Market Access, Country Health & Value, and Country Teams to develop strategies to increase access to global established products. Implemented Affordability and Patient Assistance Programs for the AI Portfolio in 7 EM. • Delivered country-specific support and guidance on managing payer negotiations within proposed price corridor. Also, developed business cases, price approvals, and deployment strategies.• Served as point-of-contact for Regional President (RP) and RP’s LT for matters related to health outcomes, evidence generation, pricing, reimbursement, and access for key products. • Collaborated with cross-functional teams (e.g., HEOR, Medical, Marketing and Commercial) to quickly identify and appropriately allocate resources per critical business needs.

Santiago, Chile

• Led the Patient Alliance Team (40 colleagues - Sales Force, District Manager, Market Access Strategists, HEOR, Communication Manager, Patient Alliance). Oversaw Patient Support Programs, strategies, and tactics (e.g., services, communication plans, campaigns). • Led the development of a cross-functionally integrated access plan across all payer channels encompassing the consideration of global deliverables, local requirements, and payer dynamics. • Prevenar National Immunization Program (NIP) was awarded for the first time. • Partnered with Commercial, Medical, Regional H&V, and Marketing colleagues to develop tenders, NIP pricing, and inclusion strategies to optimize access to Pfizer portfolio. • Built relations with Patient Advocacy Groups and NGOs to improve Pfizer’s reputation. Advocated MOH to modify policy to cover reimbursement for high value medications. Enbrel and Xeljanz were the first two brands included in this new policy.

New York, Ny

• Coordinated all phases of multiple products within a category or therapeutic area, oversaw profitgenerating sales, marketing, and/or access group activities.• Consistently attained rigorous profit and loss targets (e.g., sales, IBA) in highly competitive markets.

New York, Ny

• Project managed regional cross-functional teams, country teams, and functional workstreams.• Coordinated internal and external supply networks to launch generic portfolio. Launched 8 molecules in 5 markets from India, Brazil, and Mexico local vendors.• Reduced supply and regulatory complexity by rationalizing business cases and SKU harmonization.

New York, Ny

• Led PGS activities (e.g., team building, resource gathering, process simplification & standardization) to ensure successful launches of non-Pfizer molecules in Asia and CauCar. • Conducted holistic portfolio assessment to optimize lot sizes to reduce inventory write-offs. • Built vendor partnerships to ensure alignment with Pfizer process and performance requirements.

New York, Ny

Senior Supply Chain Manager (2008 – 2010)Demand & Supply Chain Manager (2003 – 2008) • Orchestrated USA market demand and supply chain efforts (e.g., short/long range forecasts, multisites volume alignment, budgeting, KPIs, inventory management, corrective action plans). • Designed and deployed highly integrated supply chain strategies and systems. • Managed multiple transitions from patent protected to loss of exclusivity products.

Rye Brook, Ny

• Drove all logistics activities, involving new products commercialization, changes, growth, and productivity efforts. Developed and deployed optimized forecasting practices and strategies. • Consolidated and operationalized volume plans from Sales & Marketing to enable supply continuity.

Rye Brook, Ny

• Collaborated with plants and distribution centers to ensure accurate sales forecasts and demand projections via participation in consensus forecasting process. Administered product allocations. • Interfaced with plants, process team members, and marketing and finance departments to develop long-range plans of finished goods inventory via skill with business trends and capacities.

Somerville, Nj

• Transferred an International Distribution Center from Texas to New Jersey with zero interruptions. • Led the start-up of the materials management function (e.g., Planning, Warehouse, Procurement, Customer Service) of the new manufacturing plant in Juárez, Mexico.